AlphaFold predicted structure
PRDM12 · Q9H4Q4

Mean pLDDT
63.6/ 100
Low
367 residues
Confidence breakdown
- Very high(≥ 90)12%
- Confident(70–90)39%
- Low(50–70)10%
- Very low(< 50)39%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
PR/SET domain 12
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFamilial dysautonomia
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy or pain disorder
BIALLELIC, autosomal or pseudoautosomalPain syndromes
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalParoxysmal central nervous system disorders
BIALLELIC, autosomal or pseudoautosomalcongenital insensitivity to pain-hypohidrosis syndrome
autosomal recessive hereditary sensory and autonomic neuropathy
hereditary disease
hereditary sensory and autonomic neuropathy
Pain insensitivity
neurodegenerative disease
thrombophilia
Wolff-Parkinson-White syndrome
Arrhythmogenic right ventricular dysplasia
familial sick sinus syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
PR domain zinc finger protein 12
Transcriptional regulator necessary for the development of nociceptive neurons, playing a key role in determining the nociceptive lineage from neural crest cell progenitors. Initiates neurogenesis and activates downstream pro-neuronal transcription factors, such as NEUROD1, BRN3A, and ISL1, specifically within nociceptive neurons, while repressing non-nociceptor cell fates. Essential for the proper function of nociceptors in adults, influencing both their excitability and their gene expression, thereby impacting how these neurons respond to various pain stimuli
PRDM12 · Q9H4Q4

Mean pLDDT
63.6/ 100
Low
367 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0